| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | NTRA Natera, Inc. | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 100 | $234.00 | $23,400.00 | - | - | - | |
| Feb 2, 2026 | NTRA Natera, Inc. | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 1,426 | $231.73 | $330,440.29 | -0.5% | - | - | |
| Jan 29, 2026 | NTRA Natera, Inc. | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 5,064 | $235.38 | $1,191,953.30 | -1.6% | - | - | |
| Jan 28, 2026 | NTRA Natera, Inc. | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,886 | $239.01 | $450,773.13 | -0.4% | - | - | |
| Jan 28, 2026 | NTRA Natera, Inc. | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,213 | $238.98 | $528,853.09 | -0.8% | - | - | |
| Jan 28, 2026 | NTRA Natera, Inc. | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 5,970 | $238.78 | $1,425,506.11 | -1.4% | - | - | |
| Jan 28, 2026 | NTRA Natera, Inc. | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,712 | $238.98 | $409,127.25 | -0.5% | - | - | |
| Jan 28, 2026 | NTRA Natera, Inc. | Sheena Jonathan | Director, CO-FOUNDER | Sell | 482 | $239.39 | $115,388.13 | - | - | - | |
| Jan 16, 2026 | BDSX BIODESIX INC | O'Kane Kieran | Chief Commercial Officer | Sell | 298 | $8.15 | $2,428.49 | -3.6% | - | - | |
| Jan 16, 2026 | BDSX BIODESIX INC | Hutton Scott | President & CEO | Sell | 970 | $8.15 | $7,904.82 | -2.4% | - | - | |
| Jan 16, 2026 | BDSX BIODESIX INC | Cowie Robin Harper | CFO, Sec'y & Treasurer | Sell | 298 | $8.15 | $2,428.49 | -2.1% | - | - | |
| Jan 16, 2026 | BDSX BIODESIX INC | Vazquez Chris | Chief Accounting Officer | Sell | 83 | $8.15 | $676.39 | -7.2% | - | - | |
| Jan 16, 2026 | BDSX BIODESIX INC | Pestano Gary Anthony | Chief Development Officer | Sell | 298 | $8.15 | $2,428.49 | -3.4% | - | - | |
| Jan 15, 2026 | CDNA CareDx, Inc. | Hanna John Walter JR | President and CEO | Sell | 10,156 | $21.05 | $213,804.11 | -1.6% | - | - | |
| Jan 13, 2026 | TWST Twist Bioscience Corp | Laponis Adam | Chief Financial Officer | Sell | 3,000 | $40.00 | $120,000.00 | -2.1% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.